军事知识服务平台
Safety evaluation of traditional Chinese medicines containing heavy metals and harmful elements
摘要 Traditional Chinese medicines(TCMs),particularly mineral drugs,constitute an integral part of the TCM treasury.Certain varieties,such as Cinnabar(HgS),Realgar(As2S2),and Red Lead(Pb3O4),inherently contain heavy metals or harmful ele-ments.Under the guidance of TCM theory and through appro-priate processing and compatibility,these substances exhibit unique clinical efficacy,[1]as exemplified in formulations such as Angong Niuhuang Pills,Cinnabar Sedative Pills,Purple Snow Powder,Bezoar Detoxifying Tablets,and Liushen Pills.While arsenic trioxide has been largely repurposed in modern med-icine for the treatment of acute promyelocytic leukemia,rep-resenting a paradigm shift from a traditional toxic agent to a modern targeted therapeutic,[2,3]the issue of toxicity remains a significant barrier to the global acceptance of mineral drugs containing heavy metals or harmful elements,thereby fostering widespread concerns regarding their safety.Therefore,safety evaluation of heavy metal-containing TCMs—balancing their unique therapeutic value against potential toxicological risks—constitutes a core challenge in the modernization and interna-tionalization of TCMs.
年,卷(期): 2026, 4(3)
机标分类号: S G250.252 H0
在线出版日期: 2026年9月30日